Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer.

IL-12 plasmid bleomycin cisplatin contrast-enhanced ultrasonography dog electrochemotherapy gene electrotransfer immunotherapy

Journal

Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658

Informations de publication

Date de publication:
2021
Historique:
received: 10 03 2021
accepted: 09 04 2021
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 8 6 2021
Statut: epublish

Résumé

Electrochemotherapy (ECT) and/or gene electrotransfer of plasmid DNA encoding interleukin-12 (GET pIL-12) are effective treatments for canine cutaneous, subcutaneous, and maxillofacial tumors. Despite the clinical efficacy of the combined treatments of ECT and GET, data on parameters that might predict the outcome of the treatments are still lacking. This study aimed to investigate whether dynamic contrast-enhanced ultrasound (DCE-US) results of subcutaneous tumors differ between tumors with complete response (CR) and tumors without complete response (non-CR) in dogs treated with ECT and GET pIL-12. Eight dogs with a total of 12 tumor nodules treated with ECT and GET pIL-12 were included. DCE-US examinations were performed in all animals before and immediately after therapy as well as 8 h and 1, 3, and 7 days later. Clinical follow-up examinations were performed 7 and 14 days, 1 and 6 months, and 1 year after treatment. Numerous significant differences in DCE-US parameters were noted between tumors with CR and non-CR tumors; perfusion and perfusion heterogeneity were lower in CR tumors than in non-CR tumors. Therefore, studies with larger numbers of patients are needed to investigate whether DCE-US results can be used to predict treatment outcomes and to make effective decisions about the need for repeated therapy or different treatment combinations in individual patients.

Identifiants

pubmed: 34095282
doi: 10.3389/fvets.2021.679073
pmc: PMC8173043
doi:

Types de publication

Journal Article

Langues

eng

Pagination

679073

Informations de copyright

Copyright © 2021 Brloznik, Kranjc Brezar, Boc, Knific, Cemazar, Milevoj, Sersa, Tozon and Pavlin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Vet Med Assoc. 2013 May 1;242(9):1255-9
pubmed: 23600783
Oncol Lett. 2018 Apr;15(4):5643-5649
pubmed: 29556301
J Transl Med. 2012 Nov 21;10:234
pubmed: 23171444
Br J Cancer. 2008 Jan 29;98(2):388-98
pubmed: 18182988
J Transl Med. 2017 May 31;15(1):122
pubmed: 28569161
In Vivo. 2009 Jan-Feb;23(1):55-62
pubmed: 19368125
Cancer Lett. 2017 Aug 1;400:205-218
pubmed: 27693635
J Vet Intern Med. 2008 Jul-Aug;22(4):826-31
pubmed: 18537879
J Feline Med Surg. 2014 Apr;16(4):291-9
pubmed: 24127456
Eur J Cancer. 2016 Aug;63:41-52
pubmed: 27267144
Acad Radiol. 2014 May;21(5):654-60
pubmed: 24703479
Vet Rec. 2016 Dec 17;179(24):627
pubmed: 27758950
Int J Surg. 2015 Sep;21 Suppl 1:S78-82
pubmed: 26123385
Target Oncol. 2010 Mar;5(1):53-8
pubmed: 20379790
Int J Surg. 2015 Jun;18:230-6
pubmed: 25917204
Vet J. 2016 Nov;217:18-25
pubmed: 27810205
Vet Comp Oncol. 2017 Dec;15(4):1187-1205
pubmed: 27506827
Future Oncol. 2012 Oct;8(10):1215-8
pubmed: 23130922
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):972-9
pubmed: 22208967
Invest Radiol. 2014 Dec;49(12):794-800
pubmed: 24991866
Eur J Surg Oncol. 2018 May;44(5):651-657
pubmed: 29402556
Cancer Gene Ther. 2010 Aug;17(8):571-8
pubmed: 20414325
PLoS One. 2013;8(3):e59557
pubmed: 23555705
Eur J Cancer. 2006 Oct;42(15):2472-9
pubmed: 16965911
Radiol Oncol. 2012 Dec;46(4):302-11
pubmed: 23412658
Front Vet Sci. 2020 Sep 29;7:575911
pubmed: 33134356
J Ultrasound Med. 2013 Jul;32(7):1145-55
pubmed: 23804337
Radiology. 2001 Apr;219(1):166-70
pubmed: 11274552
Eur Urol. 2001 Sep;40(3):285-93
pubmed: 11684844
Equine Vet J. 2012 Mar;44(2):214-20
pubmed: 21793876
Melanoma Res. 2005 Feb;15(1):45-51
pubmed: 15714120
Radiol Oncol. 2019 Oct 10;53(4):415-426
pubmed: 31600140
J Cell Mol Med. 2015 Mar;19(3):664-75
pubmed: 25628149
Radiology. 2011 May;259(2):406-13
pubmed: 21292869
Biochim Biophys Acta. 2002 Jan 15;1569(1-3):51-8
pubmed: 11853957
Radiol Oncol. 2017 Sep 14;51(3):286-294
pubmed: 28959165
Vet J. 2010 Jan;183(1):58-62
pubmed: 18922713
Invest Radiol. 2012 Dec;47(12):711-6
pubmed: 23095862
Res Vet Sci. 2019 Feb;122:40-49
pubmed: 30453179
Radiol Oncol. 2017 Dec 7;52(1):98-104
pubmed: 29520211
Anticancer Res. 1999 Sep-Oct;19(5B):4017-22
pubmed: 10628347
Vaccines (Basel). 2020 Sep 17;8(3):
pubmed: 32957424
Cancer. 1998 Jul 1;83(1):148-57
pubmed: 9655305
Vet Comp Oncol. 2017 Jun;15(2):641-654
pubmed: 26840222
J Ultrasound Med. 2007 Jun;26(6):749-56
pubmed: 17526606
Eur J Cancer. 2016 Jul;62:132-7
pubmed: 27189322
Arch Dermatol. 1996 Nov;132(11):1353-7
pubmed: 8915314
Vet Med Sci. 2020 Aug;6(3):290-298
pubmed: 31910331
Expert Rev Anticancer Ther. 2010 May;10(5):729-46
pubmed: 20470005
Can Vet J. 2013 Jun;54(6):606-9
pubmed: 24155455
Lancet Oncol. 2017 Mar;18(3):e143-e152
pubmed: 28271869
Abdom Radiol (NY). 2018 Apr;43(4):977-997
pubmed: 29198008
AJR Am J Roentgenol. 2011 Jan;196(1):W13-7
pubmed: 21178025
Clin Imaging. 2020 Apr;60(2):209-215
pubmed: 31927496
Vet J. 2010 Oct;186(1):58-63
pubmed: 19692273
Ann Oncol. 2016 Oct;27(10):1922-8
pubmed: 27502701
Radiol Oncol. 2018 Oct 18;52(4):383-391
pubmed: 30352044
Strahlenther Onkol. 2009 Nov;185(11):756-62
pubmed: 19899010
Clin Cancer Res. 2007 Mar 15;13(6):1801-9
pubmed: 17363536
Radiology. 2011 Jan;258(1):291-300
pubmed: 20980447
J Am Coll Cardiol. 2009 Jan 6;53(1):32-8
pubmed: 19118722
J Cutan Med Surg. 2006 May-Jun;10(3):115-21
pubmed: 17241586
J Surg Oncol. 2014 Sep;110(3):320-7
pubmed: 24782355
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Radiol Oncol. 2016 Feb 16;50(1):14-20
pubmed: 27069445
Med Sci Monit. 2017 Jul 14;23:3428-3436
pubmed: 28708818
Radiol Oncol. 2020 Mar 7;54(1):68-78
pubmed: 32187017
J Vet Intern Med. 2011 Mar-Apr;25(2):407-11
pubmed: 21382075
Mol Ther. 2003 Nov;8(5):738-45
pubmed: 14599806
Radiol Oncol. 2011 Mar;45(1):31-9
pubmed: 22933932
Ultrasound Q. 2016 Jun;32(2):116-25
pubmed: 27233070
Eur J Surg Oncol. 2020 Sep;46(9):1628-1633
pubmed: 32387070
Int J Surg. 2017 Aug;44:26-32
pubmed: 28624558
Clin Cancer Res. 2010 Feb 15;16(4):1216-25
pubmed: 20145174
Korean J Radiol. 2018 Jul-Aug;19(4):682-691
pubmed: 29962874
J Gastroenterol Hepatol. 2014 Mar;29(3):576-80
pubmed: 24118042
Curr Gene Ther. 2010 Aug;10(4):300-11
pubmed: 20560875
Clin Cancer Res. 2000 Mar;6(3):863-7
pubmed: 10741708

Auteurs

Maja Brloznik (M)

Veterinary Faculty, Small Animal Clinic, University of Ljubljana, Ljubljana, Slovenia.

Simona Kranjc Brezar (S)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Nina Boc (N)

Department of Radiology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Tanja Knific (T)

Institute of Food Safety, Feed and Environment, Veterinary Faculty, University of Ljubljana, Ljubljana, Slovenia.

Maja Cemazar (M)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Health Sciences, University of Primorska, Izola, Slovenia.

Nina Milevoj (N)

Veterinary Faculty, Small Animal Clinic, University of Ljubljana, Ljubljana, Slovenia.

Gregor Sersa (G)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Health Sciences, University of Ljubljana, Ljubljana, Slovenia.

Natasa Tozon (N)

Veterinary Faculty, Small Animal Clinic, University of Ljubljana, Ljubljana, Slovenia.

Darja Pavlin (D)

Veterinary Faculty, Small Animal Clinic, University of Ljubljana, Ljubljana, Slovenia.

Classifications MeSH